Evidence map›Paper›PMID 39837584›Full record

ArticleBMJ global health2025

Incidence, long-term predictors and progression of chronic kidney disease among African migrants and non-migrants: the transcontinental population-based prospective RODAM cohort study.

Muhulo Muhau Mungamba, Felix P Chilunga, Eva L van der Linden, Erik Beune, Engwa A Godwill, Charles F Hayfron-Benjamin, Karlijn Meeks, Samuel N Darko, Sampson Twumasi-Ankrah, Ellis Owusu-Dabo and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. CKD in Migrants: From Epidemiology to Challenges.Kidney international reports · 2026
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Muhulo Muhau MungambaPublic and Occupational Health, University of Amsterdam, Amsterdam, The Netherlands m.m.mungamba@amsterdamumc.nl.ORCID http://orcid.org/0000-0003-3676-6924
Felix P ChilungaDepartment of Public and Occupational Health, University of Amsterdam, Amsterdam, The Netherlands.
Eva L van der LindenDepartment of Public and Occupational Health, University of Amsterdam, Amsterdam, The Netherlands.
Erik BeuneDepartment of Public and Occupational Health, University of Amsterdam, Amsterdam, The Netherlands.
Engwa A GodwillDepartment of Biological and Environmental Sciences, Walter Sisulu University, Mthatha, South Africa.
Charles F Hayfron-BenjaminDepartment of Public and Occupational Health, University of Amsterdam, Amsterdam, The Netherlands.
Karlijn MeeksDepartment of Public and Occupational Health, University of Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-3032-405X
Samuel N DarkoDepartment of Molecular Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Sampson Twumasi-AnkrahDepartment of Statistics and Actuarial Science, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Ellis Owusu-DaboKwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Liffert VogtDepartment of Internal Medicine, University of Amsterdam, Amsterdam, The Netherlands.
Bert-Jan H van den BornDepartment of Vascular Medicine, University of Amsterdam, Amsterdam, The Netherlands.
Benedicta N ChungagDepartment of Biological and Environmental Sciences, Walter Sisulu University, Mthatha, South Africa.
Charles AgyemangPublic and Occupational Health, University of Amsterdam, Amsterdam, The Netherlands.

Funding

Genetic epidemiology of complex diseasesZIAHG200362 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI ROTIMI, CHARLES · 2009 to 2025
$54.7M
Unravelling the Role of Epigenetics and Cytokines in Type 2 Diabetes among African-ancestry PopulationsR00DK131018 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI Karlijn Anna Catharina Meeks · 2025 to 2026
$492k
Unravelling the Role of Epigenetics and Cytokines in Type 2 Diabetes among African-ancestry PopulationsK99DK131018 · NIDDK · NATIONAL HUMAN GENOME RESEARCH INST · PI MEEKS, KARLIJN ANNA CATHARINA · 2023 to 2023
$0k
Intramural NIH HHS ZIA HG200362NIDDK NIH HHS K99 DK131018NIDDK NIH HHS R00 DK131018
6 · The paper itself

Abstract

backgroundLimited longitudinal data exist on chronic kidney disease (CKD) in African populations undergoing epidemiological transitions. We investigated incidence, long-term predictors and progression of CKD among Ghanaians residing in Ghana and Ghanaian migrants in the Netherlands (Amsterdam). METHODS AND

findingsWe analysed data from 2183 participants in the transcontinental population-based prospective Research on Obesity and Diabetes among African Migrants cohort, followed for approximately 7 years. CKD incidence and its progression to end-stage kidney disease (ESKD) were defined using Kidney Disease: Improving Global Outcomes (KDIGO) criteria. CKD incidence was calculated using age- and sex standardisation for those without CKD at baseline. Long-term predictors of CKD incidence were identified using one-step robust Poisson regression. CKD progression to ESKD from baseline was also assessed using robust Poisson regressions. Overall age- and sex standardised CKD incidence was 11.0% (95% CI 9.3% to 12.3%) in the population, with Ghanaians residing in Amsterdam at (7.6%; 5.7% to 9.5%) and Ghanaians residing in Ghana at (12.9%; 10.9% to 14.9%). Within Ghana, rural Ghanaians had similar CKD incidence to urban Ghanaians (12.5%; 8.5% to 15.5% vs 12.3%; 8.2% to 15.8%). Residence in Amsterdam was associated with lower CKD incidence compared with Ghana after adjustments (incidence rate ratio=0.32; 0.13-0.77). CKD incidence predictors were advanced age, female sex, alcohol consumption, uric acid levels and hypertension. CKD progression to ESKD was 2.3% among Ghanaians residing in Ghana and 0.0% among Ghanaians residing in Amsterdam.

conclusionOne-tenth of Ghanaians developed CKD over 7 years, with higher incidence in Ghana compared with Europe. Age, female sex, alcohol use, uric acid levels and hypertension were predictive factors. CKD progression to ESKD was minimal. High CKD incidence among Ghanaians, especially those residing in Ghana, calls for in-depth assessment of contributing factors and targeted interventions.

Indexed as

Renal Insufficiency, ChronicTransients and MigrantsAdultAgedDisease ProgressionFemaleGhanaHumansIncidenceKidney Failure, ChronicMaleMiddle AgedNetherlandsProspective StudiesRisk FactorsCardiovascular diseaseCohort studyEpidemiologyGlobal HealthPublic Health

Identifiers

PMID39837584
PMCPMC11749268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.